Clinical implications of specific pathogenic and likely pathogenic variant (LP/PV) types and locations in the BRCA1 or BRCA2 tumor-suppressor genes remain to be elucidated.
ASSOCIATION BETWEEN TYPE AND LOCATION OF GERMLINE BRCA1/2 PATHOGENIC OR LIKELY PATHOGENIC VARIANTS WITH PHENOTYPE AND PROGNOSIS IN YOUNG PATIENTS WITH BREAST CANCER: RESULTS FROM AN INTERNATIONAL COHORT STUDY
Annals of Oncology | | A. Toss, E. Blondeaux, E. Tenedini, L. Bonamici, R. Graffeo, L. Livraghi, C. Villarreal-Garza, R.Bernstein Molho, A. Kwong, J. Balmana, H. Wildiers, E. Agostinetto, K.A. Phillips, K. Pogoda, T. Renaud, C. Rousset-Jablonski, A. Ferrari, H.C.F. Moore, F.A. Peccatori, S. Paluch-Shimon, R. Fruscio, C. Micheri, S.M. Wong, W. Cui, C. Vernieri, M. Lee, L. De Marchis, F.J. Couch, L. Del Mastro, F. Puglisi, P.A. Meireles, Z. Kemp, A. Matikas, J. Plichta, M. Del Pilar Estevez-Diz, A. Di Meglio, N. Cichowska-Cwalinska, C. Gianni, R. Yerushalmi, R. Sanchez-Bayona, B. Mrinakova, L. Matos, G. Bianchini, M. Caleffi, A. Krivokuca, Y. Abdou, M. Mariño-Mariño, A. Parokonnaya, M. Okano, N. Antone, C. Saavedra, A. Sonnenblick, R. Duchnowska, H.L. Pais, N. Harbeck, L. Cortesi, V. Delucchi, C. De Angelis, M. Lambertini
Topics: breast-cancer, research